Repare Therapeutics Q2 EPS $(0.28) Beats $(0.78) Estimate, Sales $30.25M Beat $7.68M Estimate
Portfolio Pulse from Benzinga Newsdesk
Repare Therapeutics reported Q2 earnings per share of $(0.28), beating the analyst consensus estimate of $(0.78) by 64.1%. The company also reported quarterly sales of $30.25 million, surpassing the analyst consensus estimate of $7.68 million by 293.87%. This represents a significant increase from the same period last year.
August 09, 2023 | 9:18 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Repare Therapeutics reported better than expected Q2 earnings and sales, which could positively impact the stock price.
Repare Therapeutics reported Q2 earnings and sales that significantly beat analyst estimates. This positive financial performance could increase investor confidence and drive up the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100